AMIX · Insider Trading
Autonomix Medical, Inc. Common Stock
Every open-market purchase and sale reported by AMIX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Trent N. Smith | CFO | A | +15,000 | — |
| 2026-09-08 | Lori Bisson | Director | A | +13,000 | — |
| 2026-09-08 | Bradley Hauser | CEO and President | A | +27,000 | — |
| 2026-09-08 | Walter V Klemp | Director | A | +13,000 | — |
| 2025-08-13 | Walter V Klemp | Director | D | −8,773 deriv. | — |
| 2025-08-13 | Bradley Hauser | CEO and President | D | −45,000 deriv. | — |
| 2025-08-13 | Trent N. Smith | CFO | D | −32,655 deriv. | — |
| 2025-08-13 | Lori Bisson | Director | D | −65,542 deriv. | — |
| 2025-08-13 | Christopher Capelli | Director | D | −3,750 deriv. | — |
| 2024-07-26 | David Andrew Robins | Director | Buy | +103,990 deriv. | — |
| 2024-06-24 | Trent N. Smith | CFO | A | +228,087 deriv. | — |
| 2024-06-24 | Lori Bisson | Director | A | +377,221 deriv. | — |
| 2024-06-24 | Walter V Klemp | Director | A | +175,452 deriv. | — |
| 2024-06-20 | BioStar Ventures III, L.P. | 10%+ Owner | Buy | +1,088,000 deriv. | — |
| 2024-06-20 | Bradley Hauser | CEO and President | A | +900,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Bradley Hauser | CEO and President | 27,000 | $56.70K |
| Walter V Klemp | Director | 20,118 | $42.25K |
| Trent N. Smith | CFO | 15,119 | $31.75K |
| Lori Bisson | Director | 13,119 | $27.55K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AMIX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.